Literature DB >> 10367034

Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men.

A C Scane1, R M Francis, A M Sutcliffe, M J Francis, D J Rawlings, C L Chapple.   

Abstract

To investigate the pathogenesis and sequelae of symptomatic vertebral fractures (VF) in men, we have performed a case-control study, comparing 91 men with VF (median age 64 years, range 27-79 years) with 91 age-matched control subjects. Medical history, clinical examination and investigations were performed in all patients and control subjects, to identify potential causes of secondary osteoporosis, together with bone mineral density (BMD) measurements. BMD was lower at the lumbar spine and all sites in the hip in patients with VF than in control subjects (p < 0.001). Potential underlying causes of secondary osteoporosis were found in 41% of men with VF, compared with 9% of control subjects (OR 7.1; 95% CI 3.1-16.4). Oral corticosteroid and anti-convulsant treatment were both associated with a significantly increased risk of VF (OR 6.1; 95% CI 1.3-28.4). Although hypogonadism was not associated with an increased risk of fracture, the level of sex hormone binding globulin was higher (p < 0.001) and the free androgen index lower (p < 0.001) in men with VF than control subjects. Other factors associated with a significantly increased risk of VF were family history of bone disease (OR 6.1; 95% CI 1.3-28.4), current smoking (OR 2.8; 95% CI 1.2-6.7) and alcohol consumption of more than 250 g/week (OR 3.8; 95% CI 1.7-8.7). Men with VF were more likely to complain of back pain (p < 0.001) and greater loss of height (p < 0.001) than control subjects, and had poorer (p < 0.001) scores for the energy, pain, emotion, sleep and physical mobility domains of the Nottingham Health Profile. We conclude that symptomatic VF in men are associated with reduced BMD, underlying causes of secondary osteoporosis such as corticosteroid and anti-convulsant treatment, family history of bone disease, current smoking and high alcohol consumption, and that they impair the perceived health of the individual.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367034     DOI: 10.1007/s001980050120

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  34 in total

1.  Psychotropic medications and the risk of fracture: a meta-analysis.

Authors:  Bahi Takkouche; Agustín Montes-Martínez; Sudeep S Gill; Mahyar Etminan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.

Authors:  H A Rudman; F Birrell; M S Pearce; S P Tuck; R M Francis; L Treadgold; K Hind
Journal:  Osteoporos Int       Date:  2019-01-08       Impact factor: 4.507

Review 3.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

4.  Physical performance and radiographic and clinical vertebral fractures in older men.

Authors:  Peggy M Cawthon; Terri L Blackwell; Lynn M Marshall; Howard A Fink; Deborah M Kado; Kristine E Ensrud; Jane A Cauley; Dennis Black; Eric S Orwoll; Steven R Cummings; John T Schousboe
Journal:  J Bone Miner Res       Date:  2014-09       Impact factor: 6.741

Review 5.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: a randomised, single-blind controlled pilot trial.

Authors:  Kim L Bennell; Bernadette Matthews; Alison Greig; Andrew Briggs; Anne Kelly; Margaret Sherburn; Judy Larsen; John Wark
Journal:  BMC Musculoskelet Disord       Date:  2010-02-17       Impact factor: 2.362

7.  Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis.

Authors:  Kenneth E S Poole; Elizabeth A Warburton; Jonathan Reeve
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

8.  Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.

Authors:  K Hayashi; M Yamamoto; Y Murakawa; M Yamauchi; H Kaji; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2009-04-22       Impact factor: 4.507

Review 9.  Back pain in osteoporotic vertebral fractures.

Authors:  R M Francis; T J Aspray; G Hide; A M Sutcliffe; P Wilkinson
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

10.  The prevalence of radiographic vertebral fractures in Mexican men.

Authors:  P Clark; F Cons-Molina; M Deleze; J O Talavera; L Palermo; S O Cummings
Journal:  Osteoporos Int       Date:  2009-11-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.